This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Morand, E.F. Articles by Littlejohn, G.O. Search for Related Content PubMed PubMed Citation Articles by Morand, E.F. Articles by Littlejohn, G.O. Pubmed/NCBI databases Medline Plus Health Information Fibromyalgia Lupus Social Bookmarking                         What's this?

Fibromyalgia Syndrome and Disease Activity in Systemic Lupus Erythematosus

Monash Rheumatology Unit, Monash Medical Centre, Melbourne

M.H. Miller

Monash Rheumatology Unit, Monash Medical Centre, Melbourne

S. Whittingham

Bumet Clinical Research Unit, Walter and Eliza Hall Institute for Medical Research, Parkville, Australia

G.O. Littlejohn

Monash Rheumatology Unit, Monash Medical Centre, Melbourne

To study the effect of fibromyalgia syndrome (FS) on the expression of systemic lupus erythematosus (SLE) and on the measurement of disease activity, we performed a cross-sectional study of subjects with SLE. Eighty-seven subjects were studied and 22 (25.3%), all female, had FS (Yunus' criteria). Disease activity and organ system involvement were assessed using the systemic lupus activity measure (SLAM) and using 10 cm visual analogue scales (VAS) completed by both physician and patient. No significant difference between FS and non-FS groups in the objective measurement of disease activity was present, median (range) SLAM scores being 5 (0-18) and 6 (0-24), respectively (NS). Similarly, expression of SLE, as measured by the prevalence of specific organ system involvement, was similar in the two groups. In contrast the prevalence of glucocorticoid use, antibodies to DSDNA and fulfilling four ACR criteria was higher in the non-FS group. The rating of SLE disease activity was affected by concomitant FS. Physician and patient disease activity VAS correlated significantly with SLAM scores in non-FS subjects (P < 0.001, Spearman analysis), whereas in FS subjects, neither physician nor patient VAS correlated with SLAM scores. We conclude that FS is prevalent in individuals with SLE and does not affect disease expression but may interfere with the rating of disease activity.

Key Words: Systemic lupus erythematosus • Fibromyalgia syndrome • Disease activity

Lupus, Vol. 3, No. 3, 187-191 (1994)
DOI: 10.1177/096120339400300310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				V. DHIR, A. LAWRENCE, A. AGGARWAL, and R. MISRA Fibromyalgia Is Common and Adversely Affects Pain and Fatigue Perception in North Indian Patients with Rheumatoid Arthritis J Rheumatol, November 1, 2009; 36(11): 2443 - 2448. [Abstract] [Full Text] [PDF]

				K. J. COLANGELO, J. E. POPE, and C. PESCHKEN The Minimally Important Difference for Patient Reported Outcomes in Systemic Lupus Erythematosus Including the HAQ-DI, Pain, Fatigue, and SF-36 J Rheumatol, October 1, 2009; 36(10): 2231 - 2237. [Abstract] [Full Text] [PDF]

				G S Alarcon, J Calvo-Alen, G McGwin Jr, A G Uribe, S M A Toloza, J M Roseman, M Fernandez, B J Fessler, L M Vila, C Ahn, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time Ann Rheum Dis, September 1, 2006; 65(9): 1168 - 1174. [Abstract] [Full Text] [PDF]

				M. Harth and J. Pope The measure of our measures Rheumatology, December 1, 2004; 43(12): 1465 - 1467. [Full Text] [PDF]

				S. Tang, H. Calkins, and M. Petri Neurally mediated hypotension in systemic lupus erythematosus patients with fibromyalgia Rheumatology, May 1, 2004; 43(5): 609 - 614. [Abstract] [Full Text] [PDF]

				M Valencia-Flores, M H Cardiel, V Santiago, M Resendiz, V A Castano, O Negrete, C Rosenberg, G Garcia-Ramos, J Alcocer, and D Alarcon-Segovia Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus Lupus, January 1, 2004; 13(1): 4 - 10. [Abstract] [PDF]

				J. Taylor, J. Skan, N. Erb, D. Carruthers, S. Bowman, C. Gordon, and D. Isenberg Lupus patients with fatigue--is there a link with fibromyalgia syndrome? Rheumatology, June 1, 2000; 39(6): 620 - 623. [Abstract] [Full Text] [PDF]

				J. C Yen, C. Neville, and P. R Fortin Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials Lupus, October 1, 1999; 8(8): 660 - 670. [Abstract] [PDF]

				A Lopez-Osa, J Jimenez-Alonso, A Garcia-Sanchez, C Sanchez-Tapia, M Perez, M I Peralta, F Gutierrez-Cabello, and G Morente Fibromyalgia in Spanish patients with systemic lupus erythematosus Lupus, May 1, 1999; 8(4): 332 - 333. [PDF]

				R. Bennett Review : The concurrence of lupus and fibromyalgia: implications for diagnosis and management Lupus, January 1, 1997; 6(6): 494 - 499. [PDF]